Canadian Agency for Drugs and Technologies in Health
From Wikipedia the free encyclopedia
 | This article needs to be updated. (April 2024) |
 |
The Canadian Agency for Drugs and Technologies in Health, or CADTH, is a Canadian national organisation that provides research and analysis to healthcare decision-makers.[1]
The organisation was established in 1989 by the country's federal government, and those of its provinces and territories.[2] Before April 2006, CADTH was known as the Canadian Coordinating Office for Health Technology Assessment (CCOHTA).[3][4]
On December 18th, 2023, The Government of Canada announced that CADTH would be superseded by the Canadian Drug Agency (CDA).[5]
Canadian Drug Agency Transition Office and Canadian Drug Agency[edit]
In 2021, The Government of Canada established The Canadian Drug Agency Transition Office or CDATO in order to move forward with promises of a National Pharmacare program announced in the 2019 Federal Budget.[6][7]
The responsibility of the CDATO was to "work with provinces, territories and key stakeholders on a vision, mandate and plan to establish a [Canadian Drug Agency] that will improve pharmaceutical system coordination and support related work." [6]
The CDATO found various shortcomings within Canada's existing pharmaceutical system, including but not limited to: fragmentation, inadequate infrastructure and poor return on investment as well as duplication of resources. [6]
On December 18th 2023, The Government of Canada announced that CDATO and CADTH would be superseded by the Canadian Drug Agency (CDA), with $89.5 million over the next five years dedicated to establishing the CDA.[5] The CDA's mandate will build upon CADTH's existing mandate and functionality, while expanding upon it using the recommendations provided the CDATO.[5]
See also[edit]
- International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH)
- Food and Drug Administration (FDA, USA)
- European Medicines Agency (EMEA, EU)
- Ministry of Health, Labour and Welfare (Japan)
- Health Canada
References[edit]
- ^ Rich, Pat (7 May 2018). "Low awareness about CADTH among practising doctors in Canada". Canadian Medical Association Journal. 190 (18): E576. doi:10.1503/cmaj.109-5595. ISSN 1488-2329. PMC 5940463. PMID 29735539.
- ^ "About CADTH". CADTH. Retrieved 6 October 2017.
- ^ "CADTH History". CADTH. Retrieved 6 October 2017.
- ^ "Pharmaceutical HTA and Reimbursement Processes – Canada". ispor.org. Archived from the original on 22 July 2018. Retrieved 22 July 2018.
- ^ a b c Canada, Health (18 December 2023). "The Government of Canada announces the creation of the Canadian Drug Agency". www.canada.ca. Retrieved 3 January 2024.
- ^ a b c "Canadian Drug Agency Transition Office". www.canada.ca. 21 February 2023. Retrieved 3 January 2024.
- ^ Government of Canada, Department of Finance (19 March 2019). "Budget 2019: Home". www.budget.canada.ca. Retrieved 3 January 2024.
External links[edit]
- CADTH — Canada
- BC Health Technology Assessment — British Columbia
- Ontario Health Technology Advisory Committee (OHTAC) — Ontario
- Institut national d'excellence en santé et en services sociaux (INESSS) — Quebec
- Contextualized Health Research Synthesis Program (CHRSP) — Newfoundland
- Drug Evaluation Alliance of Nova Scotia (DEANS) — Maritimes
- Other HTA organizations in Canada
- Another list of HTA organizations in Canada
- International Network of Agencies for Health Technology Assessment
| International | |
|---|---|
| National | |
 | This article about an organization in Canada is a stub. You can help Wikipedia by expanding it. |